SEPTInvestingStart Free

TRDA 8-K: SEC filing

Entrada Therapeutics

Filed with the SEC on · accession 0001689375-26-000063

TRDA filed a 8-K (current report) with the SEC on Nov 5, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -10.1% by the first close after the filing.

Summary of the filing

Entrada Therapeutics reported Q3 2026 financial results, highlighting clinical progress across its DMD programs (ELEVATE-44-201 and ELEVATE-45-201), an orphan drug designation for ENTR-601-45, and an extended cash runway into Q4 2027 with $193 million in cash and marketable securities.

For details, click here →How to read a 8-K →

Key details

Cash, cash equivalents and marketable securities as of September 30, 2026$193.0M
IssuerEntrada Therapeutics, Inc.
Partner for vx-670 in dm1Vertex Pharmaceuticals
Chief executive officerDipal Doshi

How TRDA stock reacted

Close before

$5.06

Nov 4, 2026

First close after

-10.08%

$4.55

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for TRDA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for TRDA?

Click here

Frequently asked questions

What did TRDA file with the SEC on Nov 5, 2026?

TRDA filed a 8-K (SEC filing). Entrada Therapeutics reported Q3 2026 financial results, highlighting clinical progress across its DMD programs (ELEVATE-44-201 and ELEVATE-45-201), an orphan drug designation for ENTR-601-45, and an extended cash runway into Q4 2027 with $193 million in cash and marketable securities.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did TRDA stock react to this filing?

TRDA closed at $5.06 before the filing and $4.55 on Nov 5, 2026 (-10.08%).

Other TRDA SEC filings

Get alerts when TRDA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
TRDA overviewTRDA analysisTRDA newsLatest SEC filings